About Homeobox even-skipped homolog protein 1
Homeobox even-skipped homolog protein 1 (EVX1) is a protein
from Homo sapiens identified by UniProt accession
P49640, 407 residues long.
MolForge cross-references it against 0 known binders and
53 disease associations.
Target properties
| Protein name | Homeobox even-skipped homolog protein 1 |
| UniProt accession | P49640 |
| Gene | EVX1 |
| Organism | Homo sapiens |
| Length | 407 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (53)
Diseases linked to this target (Open Targets).
- systolic blood pressure · score 0.40
- diastolic blood pressure · score 0.40
- alcohol consumption measurement · score 0.39
- alcohol drinking · score 0.39
- mean arterial pressure · score 0.38
- hypertension · score 0.37
- pulse pressure measurement · score 0.30
- Diuretic use measurement · score 0.29
- drug use measurement · score 0.24
- vital capacity · score 0.24
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P49640-F1 | alphafold | PREDICTED | 56.18 | — |
Amino-acid sequence (407 residues)
MESRKDMVVF LDGGQLGTLV GKRVSNLSEA VGSPLPEPPE KMVPRGCLSP RAVPPATRER GGGGPEEEPV DGLAGSAAGP GAEPQVAGAA MLGPGPPAPS VDSLSGQGQP SSSDTESDFY EEIEVSCTPD CATGNAEYQH SKGSGSEALV GSPNGGSETP KSNGGSGGGG SQGTLACSAS DQMRRYRTAF TREQIARLEK EFYRENYVSR PRRCELAAAL NLPETTIKVW FQNRRMKDKR QRLAMTWPHP ADPAFYTYMM SHAAAAGGLP YPFPSHLPLP YYSPVGLGAA SAASAAASPF SGSLRPLDTF RVLSQPYPRP ELLCAFRHPP LYPGPAHGLG ASAGGPCSCL ACHSGPANGL APRAAAASDF TCASTSRSDS FLTFAPSVLS KASSVALDQR EEVPLTR
Explore Homeobox even-skipped homolog protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets